Gene expression analysis of DAC treated AML: high impact or tumor suppressor gene expression changes
Ontology highlight
ABSTRACT: DAC represents a therapeutic option for elderly AML patients. However, there is still a lack of data for valid biomarkers in respect to response. We executed a gene expression analysis prior to treatment to evaluate gene expression patterns associated with response that might be used to predict DAC therapy outcome. In our cohort an objective ORR of 27% was seen. In a class comparison analysis 333 genes were identified that correlated significantly with response. In this gene signature genes that were prior associated with adverse outcome to regular chemotherapy were enriched in the response group. Interistingly for the non response cohort TSG showed an increased expression, suggesting that epigenetic silencing due to promoter hypermethylation might play a lesser role in theses leukemia pathogenesis.
ORGANISM(S): Homo sapiens
PROVIDER: GSE84334 | GEO | 2016/12/31
SECONDARY ACCESSION(S): PRJNA328929
REPOSITORIES: GEO
ACCESS DATA